Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
LY-3849891 in Metabolic Dysfunction Associated Steatohepatitis: NCT05395481 Clinical Landscape Report 2026
16 October 2026
NCT05395481 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
HEC-96719 in Metabolic Dysfunction Associated Steatohepatitis: NCT05397379 Clinical Landscape Report 2026
16 October 2026
NCT05397379 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Batoclimab in Myasthenia Gravis: NCT05403541 Clinical Landscape Report 2026
16 October 2026
NCT05403541 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rencofilstat in Fibrosis, Liver: NCT05402371 Clinical Landscape Report 2026
16 October 2026
NCT05402371 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Docosahexaenoic acid in Hemoglobin SC Disease: CTRI/2022/06/042963 Clinical Landscape Report 2026
16 October 2026
CTRI/2022/06/042963 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Flurimedrimer(18F) in Alzheimer Disease: NCT05395624 Clinical Landscape Report 2026
16 October 2026
NCT05395624 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dazucorilant in Amyotrophic Lateral Sclerosis: NCT05407324 Clinical Landscape Report 2026
16 October 2026
NCT05407324 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Decitabine/Tetrahydrouridine in Anemia, Sickle Cell: NCT05405114 Clinical Landscape Report 2026
16 October 2026
NCT05405114 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
[68Ga]CBP8 in Idiopathic Pulmonary Fibrosis: NCT05417776 Clinical Landscape Report 2026
16 October 2026
NCT05417776 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lomustine in Recurrent Glioblastoma: NCT05410301 Clinical Landscape Report 2026
16 October 2026
NCT05410301 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GDC-3280 in Idiopathic Pulmonary Fibrosis: NCT05424887 Clinical Landscape Report 2026
16 October 2026
NCT05424887 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rifaximin in Hematologic Diseases: PACTR202206488890527 Clinical Landscape Report 2026
16 October 2026
PACTR202206488890527 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.